Human epididymis protein 4 increases specificity for the detection of invasiive epithelial ovarian cancer in premenopausal women presenting with an adnexal mass

被引：1
|
作者：
Holcomb, K. [1 ]
Miller, C. [2 ]
Vucetic, Z. [2 ]
Knapp, R. [3 ]
机构：
[1] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[2] Fujirebio Diagnost Inc, Malverne, PA USA
[3] Harvard Univ, Sch Med, Boston, MA USA
来源：
GYNECOLOGIC ONCOLOGY | 2011年 / 121卷 / 01期
关键词：
D O I：
10.1016/j.ygyno.2010.12.167
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
160
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [21] NEW INDEX BASED ON HUMAN EPIDIDYMIS PROTEIN 4 PERFORMS BETTER THAN RISK OF OVARIAN MALIGNANCY ALGORITHM IN PREMENOPAUSAL PATIENTS WITH PELVIC MASS
    Katsyuba, M.
    Khasanov, R.
    Madzhidov, T.
    Usmanova, G.
    Akhmetzianova, A.
    Muratova, G.
    Fakhrutdinova, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A366 - A367
  • [22] Utility of human epididymis protein 4 serum marker for the detection of adnexal malignancy: a multicentric prospective study
    Zapardiel, Ignacio
    Gorostidi, Mikel
    Ravaggi, Antonella
    Allende, Maria T.
    Silveira, Margarida
    Macuks, Ronalds
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2017, 26 (04) : 346 - 350
  • [23] HUMAN EPIDIDYMIS PROTEIN 4 AS BIOMARKER FOR THE DIFFERENTIATION BETWEEN PRIMARY OVARIAN CANCER AND OVARIAN METASTASES
    Boldingh, Q. J. J.
    Stiekema, A.
    Lok, C. A. R.
    Boot, H.
    van Driel, W. J.
    Kenter, G. G.
    Korse, C. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 280 - 281
  • [24] The "risk of ovarian malignancy algorithm" for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass
    Montagnana, Martina
    Danese, Elisa
    Ruzzenente, Orazio
    Giudici, Silvia
    Gelati, Matteo
    Salvagno, Gian Luca
    Franchi, Massimo
    Lippi, Giuseppe
    Guidi, Gian Cesare
    BIOCHIMICA CLINICA, 2011, 35 (01) : 30 - 35
  • [25] Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women
    Fujiwara, Hiroyuki
    Suzuki, Mitsuaki
    Takeshima, Nobuhiro
    Takizawa, Ken
    Kimura, Eizo
    Nakanishi, Toru
    Yamada, Kyosuke
    Takano, Hirokuni
    Sasaki, Hiroshi
    Koyama, Koji
    Ochiai, Kazunori
    TUMOR BIOLOGY, 2015, 36 (02) : 1045 - 1053
  • [26] Human Epididymis Protein 4 (HE4). A tumor marker in the diagnosis of ovarian cancer
    Zulauf, N.
    Bendels, M. H.
    Bauer, J.
    Braun, M.
    Volante, G.
    Oremek, G. M.
    Groneberg, D. A.
    Brueggmann, D.
    ZENTRALBLATT FUR ARBEITSMEDIZIN ARBEITSSCHUTZ UND ERGONOMIE, 2019, 69 (01): : 30 - 32
  • [27] Human epididymis secretory protein 4 in serum (HE4) as a marker of ovarian cancer
    Qu, K. Z.
    Li, H.
    Whitmire, R.
    Sferruzza, A.
    Bender, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] WHY WE REALLY NEED THE HUMAN EPIDIDYMIS PROTEIN 4 IN THE PREOPERATIVE ASSESSMENT OF PREMENOPAUSAL PATIENTS WITH PELVIC MASS
    Katsyuba, Mikhail
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A428 - A428
  • [29] The clinical importance of IFN-γ γ and human epididymis protein 4 in Egyptian patients with epithelial ovarian cancer combined with HPV infection
    Mohamed, Nourhan E.
    Fattah, Nasra F. Abdel
    Seadawy, Mohamed G.
    Lymona, Ahmed M.
    Nasr, Sarah S.
    El Leithy, Asmaa A.
    Abdelwahed, Fatma M.
    Nassar, Auhood
    HUMAN IMMUNOLOGY, 2024, 85 (05)
  • [30] Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter
    Berry, NB
    Cho, YM
    Harrington, MA
    Williams, SD
    Foley, J
    Nephew, KP
    GYNECOLOGIC ONCOLOGY, 2004, 92 (03) : 896 - 904
12345